KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
62 hedge funds and large institutions have $1.18B invested in Kinnate Biopharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+7
Holders Change %
+12.73%
% of All Funds
1.09%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
25
Increased
13
Reduced
9
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
$37.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$40.7M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
$29.1M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
$7.43M |
| 5 |
State Street
Boston,
Massachusetts
|
$5.71M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Wellington Management Group
Boston,
Massachusetts
| – | -$227K | -5,698 | Closed |
|
|
HF
77
HRT Financial
New York
| – | -$223K | -5,617 | Closed |
|
|
PHK
78
Point72 Hong Kong
Hong Kong
| – | -$217K | -5,463 | Closed |
|
79
Rockefeller Capital Management
New York
| – | -$129K | -3,260 | Closed |
|
|
PFO
80
Pathstone Family Office
Englewood,
New Jersey
| – | -$8K | -198 | Closed |
|